COLO-B.CO vs. NVZMY
COLO-B.CO (Coloplast A/S) and NVZMY (Novozymes AS) are both stocks. COLO-B.CO operates in Medical Instruments & Supplies (Healthcare), while NVZMY operates in Specialty Chemicals (Basic Materials). Over the past 10 years, COLO-B.CO returned 0.12%/yr vs 2.95%/yr for NVZMY. At a 0.30 correlation, their price movements are largely independent.
Performance
COLO-B.CO vs. NVZMY - Performance Comparison
Loading charts...
Different Trading Currencies
COLO-B.CO is traded in DKK, while NVZMY is traded in USD. To make them comparable, the NVZMY values have been converted to DKK using the latest available exchange rates.
Returns By Period
In the year-to-date period, COLO-B.CO achieves a -28.89% return, which is significantly lower than NVZMY's -8.37% return. Over the past 10 years, COLO-B.CO has underperformed NVZMY with an annualized return of 0.12%, while NVZMY has yielded a comparatively higher 2.95% annualized return.
COLO-B.CO
- 1D
- 1.21%
- 1M
- -5.32%
- YTD
- -28.89%
- 6M
- -33.14%
- 1Y
- -36.22%
- 3Y*
- -21.69%
- 5Y*
- -14.79%
- 10Y*
- 0.12%
NVZMY
- 1D
- 0.11%
- 1M
- -6.01%
- YTD
- -8.37%
- 6M
- -7.76%
- 1Y
- -20.21%
- 3Y*
- 3.42%
- 5Y*
- -2.36%
- 10Y*
- 2.95%
COLO-B.CO vs. NVZMY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
COLO-B.CO Coloplast A/S | -28.89% | -27.73% | 4.47% | -2.40% | -27.80% | 26.10% | 14.67% | 39.66% | 25.89% | 6.74% |
NVZMY Novozymes AS | -8.37% | 0.90% | 10.88% | 9.33% | -34.62% | 57.70% | 7.94% | 12.86% | -17.00% | 48.90% |
Correlation
The correlation between COLO-B.CO and NVZMY is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Aug 31, 2007 | 0.30 |
The correlation between COLO-B.CO and NVZMY shifts across timeframes, from 0.21 (1 year) to 0.31 (10 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
COLO-B.CO vs. NVZMY — Risk / Return Rank
COLO-B.CO
NVZMY
COLO-B.CO vs. NVZMY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Coloplast A/S (COLO-B.CO) and Novozymes AS (NVZMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| COLO-B.CO | NVZMY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.59 | ||
| Sortino ratioReturn per unit of downside risk | -0.91 | ||
| Omega ratioGain probability vs. loss probability | 0.76 | 0.87 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | -0.96 | -0.69 | -0.27 |
| Martin ratioReturn relative to average drawdown | -2.00 | -1.15 | -0.85 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| COLO-B.CO | NVZMY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.43 | -0.84 | -0.59 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.57 | -0.09 | -0.48 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.00 | 0.11 | -0.11 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.50 | -0.05 | +0.55 |
Drawdowns
COLO-B.CO vs. NVZMY - Drawdown Comparison
The maximum COLO-B.CO drawdown since its inception was -63.31%, smaller than the maximum NVZMY drawdown of -83.94%. Use the drawdown chart below to compare losses from any high point for COLO-B.CO and NVZMY.
Loading charts...
Drawdown Indicators
| COLO-B.CO | NVZMY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.31% | -83.94% | +20.63% |
Max Drawdown (1Y)Largest decline over 1 year | -38.33% | -29.56% | -8.77% |
Max Drawdown (3Y)Largest decline over 3 years | -58.16% | -29.56% | -28.60% |
Max Drawdown (5Y)Largest decline over 5 years | -63.31% | -47.59% | -15.72% |
Max Drawdown (10Y)Largest decline over 10 years | -63.31% | -47.59% | -15.72% |
Current DrawdownCurrent decline from peak | -62.76% | -51.60% | -11.16% |
Average DrawdownAverage peak-to-trough decline | -12.43% | -51.40% | +38.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.17% | 17.63% | +0.54% |
Volatility
COLO-B.CO vs. NVZMY - Volatility Comparison
Coloplast A/S (COLO-B.CO) and Novozymes AS (NVZMY) have volatilities of 7.19% and 6.93%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| COLO-B.CO | NVZMY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.19% | 6.93% | +0.26% |
Volatility (6M)Calculated over the trailing 6-month period | 20.57% | 17.03% | +3.54% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.66% | 24.02% | +1.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.29% | 26.15% | +0.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.92% | 25.92% | -1.00% |
Dividends
COLO-B.CO vs. NVZMY - Dividend Comparison
COLO-B.CO's dividend yield for the trailing twelve months is around 5.99%, more than NVZMY's 1.81% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO-B.CO Coloplast A/S | 5.99% | 4.21% | 2.80% | 2.72% | 2.46% | 1.65% | 1.94% | 2.06% | 2.64% | 3.04% | 2.83% | 2.24% |
NVZMY Novozymes AS | 1.81% | 1.51% | 1.03% | 2.68% | 1.68% | 0.69% | 0.91% | 1.03% | 1.10% | 1.64% | 0.95% | 0.60% |
Financials
COLO-B.CO vs. NVZMY - Financials Comparison
This section allows you to compare key financial metrics between Coloplast A/S and Novozymes AS. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
COLO-B.CO and NVZMY have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for COLO-B.CO and NVZMY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer